Mannitol Versus Hypertonic Saline Solution in the Treatment of Elevated Intracranial Pressure
Equimolar Doses of Mannitol and Hypertonic Saline in the Treatment of Elevated Intracranial Pressure
1 other identifier
interventional
20
1 country
1
Brief Summary
The purpose of this study is to determine whether mannitol is as effective as hypertonic saline solution in the treatment of elevated intracranial pressure in patients with brain injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started Oct 2002
Typical duration for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2002
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2005
CompletedFirst Submitted
Initial submission to the registry
March 12, 2007
CompletedFirst Posted
Study publicly available on registry
March 13, 2007
CompletedMarch 13, 2007
March 1, 2007
March 12, 2007
March 12, 2007
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Magnitude of ICP and of cerebral perfusion pressure (CPP) changes following osmotherapy during a study period of 120 min.
Secondary Outcomes (3)
Effects of treatment on blood flow velocities (FV) of middle cerebral artery using continuous transcranial doppler.
Effects of treatment on brain oxygenation using brain tissue oxygen tension (PbrO2) probe.
Effects of treatment on biochemical data (serum sodium and osmolality, urine output).
Interventions
Eligibility Criteria
You may qualify if:
- age 18 or older
- sustained elevated intracranial pressure to more than 20 mmHg for more than 10 min
- mechanically ventilated in stable conditions for more than 2 hours prior to the study
- serum osmolality ranged between 280 and 320 mOsm/kg
You may not qualify if:
- imminent cranial or extracranial surgery
- leakage or drainage of cerebral spinal fluid
- unstable respiratory and hemodynamic conditions
- oliguric renal failure
- anemia
- use of mannitol or HSS in the previous 6 hours
- concomitant use of thiopentone
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hopital Michallon
Grenoble, 38043, France
Related Publications (2)
Battison C, Andrews PJ, Graham C, Petty T. Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med. 2005 Jan;33(1):196-202; discussion 257-8. doi: 10.1097/01.ccm.0000150269.65485.a6.
PMID: 15644669RESULTVialet R, Albanese J, Thomachot L, Antonini F, Bourgouin A, Alliez B, Martin C. Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol. Crit Care Med. 2003 Jun;31(6):1683-7. doi: 10.1097/01.CCM.0000063268.91710.DF.
PMID: 12794404RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Francois Payen, MD, PhD
University Hospital, Grenoble
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 12, 2007
First Posted
March 13, 2007
Study Start
October 1, 2002
Study Completion
June 1, 2005
Last Updated
March 13, 2007
Record last verified: 2007-03